Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check6 days agoChange DetectedThe page now shows a 403 Forbidden error page with a minimal header and a Home link. The detailed IPF-PRO/ILD-PRO registry content and study details have been removed.SummaryDifference21%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a new revision of the study record page with potential minor fixes or clarifications.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded University of Vermont Lung Center in Colchester, VT and expanded Vermont locations. Updated multiple site contacts and recruitment statuses across centers, and removed several previously listed contacts/locations as sites were terminated.SummaryDifference1%

- Check48 days agoChange DetectedA new publication citation for the IPF-PRO Registry was added to Publications. The page version was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a minor backend or UI update to the ClinicalTrials.gov page.SummaryDifference0.0%

- Check77 days agoChange DetectedPhone number formatting changed from 216-445-0574 to 2164450574, and new date stamps were added to reflect administrative page updates. These changes relate to page metadata rather than the core study content.SummaryDifference0.2%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.